Key result
A history of cancer in patients admitted for ACS was associated with increased in-hospital all-cause death and cardiac death.
Why the study?
Patients with cancer admitted for ACS and/or PCI represent a growing, high-risk population, but the influence of co-existing cancer on mortality remains unclear.
Does a history of cancer increase mortality in patients admitted for ACS and/or PCI?
Meta-Analysis (n=334,501)
Does a history of cancer increase mortality in patients admitted for ACS and/or PCI?
A history of cancer significantly increases the risk of early and late all-cause and cardiac mortality, as well as bleeding, in patients presenting with ACS or undergoing PCI.
Answers are grounded in this paper and cite their sources.
May heighten vigilance for mortality risk in ACS with cancer history; leaves open whether targeted strategies improve outcomes.
BACKGROUND: Patients with cancer admitted for an acute coronary syndrome (ACS) and/or percutaneous coronary intervention (PCI) represent a growing and high-risk population. The influence of co-existing cancer on mortality remains unclear in such patients. We aimed to assess the impact of cancer on early and late, all-cause and cardiac mortality in the setting of ACS and/or PCI. METHODS: We performed a systematic review and meta-analysis of studies comparing outcomes of patients with and without a history of cancer admitted for ACS and/or PCI. RESULTS: Six studies including 294,528 ACS patients and three studies including 39,973 PCI patients were selected for our meta-analysis. Patients with cancer had increased rates of in-hospital all-cause death (RR 1.74 [1.22; 2.47]), cardiac death (RR 2.44 [1.73; 3.44]) and bleeding (RR 1.64 [1.35; 1.98]) as well as one-year all-cause death (RR 2.62 [1.2; 5.73]) and cardiac death (RR 1.89 [1.25; 2.86]) in ACS studies. Rates of long term all-cause (RR 1.96 [1.52; 2.53]) but not cardiac death were higher in cancer patients admitted for PCI. CONCLUSION: Cancer patients represent a high-risk population both in the acute phase and at long-term after an ACS or PCI. The magnitude of the risk of mortality should however be tempered by the heterogeneity among studies. Early and long term optimal management of such patients should be promoted in clinical practice.
No takes yet. Share an insight, caveat, or question.
Roule et al. (2020) conducted a meta-analysis in Acute coronary syndrome (ACS) and/or percutaneous coronary intervention (PCI) (n=334,501). History of cancer vs. No history of cancer was evaluated on In-hospital all-cause death in ACS patients (RR 1.74, 95% CI 1.22-2.47). A history of cancer in patients admitted for ACS was associated with increased in-hospital all-cause death and cardiac death.
Synapse has enriched 10 related papers. Consider them for comparative context: